185 related articles for article (PubMed ID: 22702254)
21. "One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
Heusner T; Gölitz P; Hamami M; Eberhardt W; Esser S; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Jun; 78(3):430-5. PubMed ID: 19945240
[TBL] [Abstract][Full Text] [Related]
22. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): the technical basis, ICRU-target volumes, problems, perspectives.
Nestle U; Kremp S; Grosu AL
Radiother Oncol; 2006 Nov; 81(2):209-25. PubMed ID: 17064802
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of gross tumor size using CT, 18F-FDG PET, integrated 18F-FDG PET/CT and pathological analysis in non-small cell lung cancer.
Yu HM; Liu YF; Hou M; Liu J; Li XN; Yu JM
Eur J Radiol; 2009 Oct; 72(1):104-13. PubMed ID: 18640802
[TBL] [Abstract][Full Text] [Related]
24. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
[TBL] [Abstract][Full Text] [Related]
25. [The role of PET in lung cancer staging].
Gärtner FC; Buermann J; Skowasch D; Biersack HJ; Essler M
Dtsch Med Wochenschr; 2015 Apr; 140(9):679-83. PubMed ID: 25924049
[TBL] [Abstract][Full Text] [Related]
26. Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application.
Seemann MD; Schaefer JF; Englmeier KH
Eur Radiol; 2007 Mar; 17(3):709-15. PubMed ID: 16909219
[TBL] [Abstract][Full Text] [Related]
27. Virtual bronchoscopy using FDG-PET/CT images for the evaluation of lung cancer.
Yildirim D; Tamam M; Sanli Y; Ozgul MA; Somay A
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1951-60. PubMed ID: 23242722
[TBL] [Abstract][Full Text] [Related]
28. PET/CT for staging and monitoring non small cell lung cancer.
Rankin S
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S27-31. PubMed ID: 18852078
[TBL] [Abstract][Full Text] [Related]
29. Sarcomatoid carcinoma of the lung mimics aspergilloma on ¹⁸F-FDG PET/CT.
Zhang Y; Li B; Shi H; Cai L; Gu Y
Hell J Nucl Med; 2015; 18(3):268-70. PubMed ID: 26574699
[TBL] [Abstract][Full Text] [Related]
30. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Vansteenkiste JF
Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
[No Abstract] [Full Text] [Related]
31. [Staging of non-small cell lung cancer. Diagnosis efficacy of structural (CT) and functional (FDG-PET) imaging methods].
Rodríguez Fernández A; Bellón Guardia ME; Gómez Río M; Ramos Font C; Sánchez-Palencia Ramos A; Llamas Elvira JM; Pedraza Muriel V
Rev Clin Esp; 2007 Dec; 207(11):541-7. PubMed ID: 18021641
[TBL] [Abstract][Full Text] [Related]
32. PET/CT in non-small cell lung cancer staging-promises and problems.
Devaraj A; Cook GJ; Hansell DM
Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
[TBL] [Abstract][Full Text] [Related]
33. Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration.
De Wever W; Stroobants S; Coolen J; Verschakelen JA
Eur Respir J; 2009 Jan; 33(1):201-12. PubMed ID: 19118231
[TBL] [Abstract][Full Text] [Related]
34. Lesion detection and characterization with context driven approximation in thoracic FDG PET-CT images of NSCLC studies.
Yang Song ; Weidong Cai ; Heng Huang ; Xiaogang Wang ; Yun Zhou ; Fulham MJ; Feng DD
IEEE Trans Med Imaging; 2014 Feb; 33(2):408-21. PubMed ID: 24235248
[TBL] [Abstract][Full Text] [Related]
35. Utility of 18F-FDG PET in evaluating cancers of lung.
Acker MR; Burrell SC
J Nucl Med Technol; 2005 Jun; 33(2):69-74; quiz 75-7. PubMed ID: 15930019
[TBL] [Abstract][Full Text] [Related]
36. F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
Subramaniam RM; Durnick DK; Peller PJ
Clin Nucl Med; 2008 Jul; 33(7):472-4. PubMed ID: 18580232
[TBL] [Abstract][Full Text] [Related]
37. Elevated FDG uptake in right middle segmental bronchus impacted with foreign body.
Xing Y; Zhao J; Chen X; Song J
Clin Nucl Med; 2009 Apr; 34(4):241-2. PubMed ID: 19300058
[TBL] [Abstract][Full Text] [Related]
38. F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.
Oven Ustaalioglu BB; Kefeli U; Bilici A; Ustaalioglu R; Seker M; Cinaral F; Dogusoy I
Clin Nucl Med; 2011 May; 36(5):367-9. PubMed ID: 21467856
[No Abstract] [Full Text] [Related]
39. Detection and staging of preinvasive lesions and occult lung cancer in the central airways with 18F-fluorodeoxyglucose positron emission tomography: a pilot study.
Pasic A; Brokx HA; Comans EF; Herder GJ; Risse EK; Hoekstra OS; Postmus PE; Sutedja TG
Clin Cancer Res; 2005 Sep; 11(17):6186-9. PubMed ID: 16144919
[TBL] [Abstract][Full Text] [Related]
40. PET scan in lung cancer: current recommendations and innovation.
Vansteenkiste JF; Stroobants SS
J Thorac Oncol; 2006 Jan; 1(1):71-3. PubMed ID: 17409830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
